Increased Risk of Cancer in relation to Gout: A Review of Three Prospective Cohort Studies with 50,358 Subjects

Table 1

Characteristics of all studies.

Study	Year	Origins	Number of subjects	Follow-up duration (years)	Baseline time	Mean age of patients	Cancer sites	Adjusted factors
Chen et al. [13]	2014	Taiwan	9,413	8	1998–2000	51.03 ± 14.52	Prostate, bladder, kidney, colorectum, liver, gallbladder and bile duct, stomach, lung, esophageal, pancreas, nasopharyngeal, brain, and oral, and so forth	Age, sex, year, and month of first diagnosis
Kuo et al. [6]	2012	Taiwan	24,088	7.8-7.9	2000–2008	42.3 ± 16.3	Prostate, bladder, colon, liver, stomach, lung, and breast, and so forth	Age and sex
Bofetta et al. [20] Men	2009	Sweden	10,500	NR	1965–1995	NR	Prostate, bladder, kidney, rectum, colon, liver and bile duct, stomach, lung, pancreas, brain, and oral, and so forth	Sex, time since first hospitalization, and gout as primary or the only diagnosis
Bofetta et al. [20] Women	2009	Sweden	6,357	NR	1965–1995	NR	Bladder, kidney, rectum, colon, liver and bile duct, stomach, lung, pancreas, brain, oral, breast, and so forth	Sex, time since first hospitalization, and gout as primary or the only diagnosis